Chairman
X4 Pharmaceuticals, Inc (XFOR)Equibles does not estimate personal net worth.
Get an email with a short summary when X4 Pharmaceuticals, Inc publishes a filing, an earnings call transcript or a press release.
Get XFOR alertsAdam Craig is recorded as Chairman at X4 Pharmaceuticals, Inc (XFOR) since August 12, 2025. X4 Pharmaceuticals, Inc reported in an 8-K filed August 12, 2025 that Adam Craig was appointed Executive Chair. Adam Craig has spoken on 2 investor events across 1 company, most recently for X4 Pharmaceuticals, Inc on September 10, 2026. X4 Pharmaceuticals, Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at X4 Pharmaceuticals, Inc includes Adam Raymond Craig, M.D., Ph.D. (CEO, Chairman and Board Member), Michael Gray (CEO), Paula Ragan (CEO) and 7 others.
“the X4 Board of Directors has appointed Adam Craig, PhD, as Executive Chair, John Volpone as President, and David Kirske as Chief Financial Officer, effectively immediately.”
“We're currently developing for a second indication a drug called Mabarixifor, which is a drug that increases the neutrophil counts in patients where they have, in conditions such as chronic neutropenia, where there are low neutrophil counts.”
“I will be making some forward-looking statements during the presentation today, and I refer you to the text in this slide. So, X4 Pharmaceuticals is primarily a Boston-based company that specializes in rare haematology conditions.”
2025-08-12–present
Biotechnology · Healthcare
Chairman
2025-08-12–present
